CytoCore®, Inc. is a biomolecular diagnostics company engaged in the design, development, and commercialization of cost-effective screening systems to assist in the early detection of cancer. CytoCore® is currently focused on the design, development, and marketing of its CytoCore Solutions™ System and related image analysis platform. The CytoCore Solutions™ System and associated products are intended to detect cancer and cancer-related diseases, and may be used in a laboratory, clinic, or doctor’s office.
The science of medical diagnostics has advanced significantly during the past decade. Much of this advance has come as a result of new knowledge of the human genome and related proteins, which form the foundation of cell biology and the functioning of the human body. Our goal is to utilize this research as a basis to develop screening and diagnostic testing products for cancer and cancer-related diseases. We believe that the success of these products will improve patient care through more accurate test performance, wider product availability and more cost-effective service delivery. We have developed an FDA-approved sample collection device, and are currently developing proteomic-based tests, analytical instruments, and related software.